Skip to main content
. 2017 May 18;16:92. doi: 10.1186/s12944-017-0481-y

Table 3.

Comparison of lipid profile in BC (pre and post treated) patients with controls

Lipid parameter (mg/dL) Controls n = 50 Pre-treated BC patients n = 130 Post-treated BC patients n = 130
TC (<200) 137.88 ± 24.45 224.4 ± 25.21* 150.2 ± 22.19* ¶
TG (<150) 114.42 ± 24.74 144.7 ± 21.28 146.2 ± 27.42
HDL (<40) 56.56 ± 14.77 55.96 ± 16.97 43.36 ± 5.62
LDL(<100) 54.16 ± 12.71 142.9 ± 25.04* 89.83 ± 26.68* ¶
TL (450-1000) 509.72 ± 37.97 718.1 ± 53.74* 579.7 ± 55.59* ¶
VLDL(<30) 22.67 ± 4.75 28.95 ± 4.25* 31.49 ± 5.71*
TC:HDL(4.0) 2.712 ± 0.84 4.48 ± 1.60 3.54 ± 0.72
TC:LDL (1-6) 2.70 ± 0.91 1.59 ± 0.17* 1.78 ± 0.53
HDL:LDL (0.5) 1.06 ± 0.45 0.39 ± 0.145* 0.51 ± 0.14 *

*p < 0.01 shows the comparison between pre-treated and post treated BC patients with controls, ¶ p < 0.01 shows the comparison between pre-treated BC patients with post treated BC patients